Vladimir Zharov
Concepts (358)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Flow Cytometry | 40 | 2021 | 515 | 10.360 |
Why?
| Photoacoustic Techniques | 25 | 2021 | 68 | 8.610 |
Why?
| Neoplastic Cells, Circulating | 21 | 2021 | 76 | 5.840 |
Why?
| Molecular Imaging | 15 | 2021 | 53 | 4.630 |
Why?
| Gold | 28 | 2020 | 139 | 4.360 |
Why?
| Nanoparticles | 21 | 2020 | 152 | 4.210 |
Why?
| Lasers | 24 | 2021 | 121 | 3.350 |
Why?
| Nanotubes, Carbon | 15 | 2020 | 66 | 3.210 |
Why?
| Light | 13 | 2020 | 74 | 3.140 |
Why?
| Acoustics | 8 | 2016 | 32 | 2.640 |
Why?
| Contrast Media | 11 | 2017 | 210 | 2.490 |
Why?
| Nanotechnology | 8 | 2015 | 36 | 2.330 |
Why?
| Erythrocytes | 8 | 2022 | 87 | 1.980 |
Why?
| Microscopy | 10 | 2018 | 62 | 1.950 |
Why?
| Metal Nanoparticles | 11 | 2020 | 85 | 1.930 |
Why?
| Animals | 63 | 2022 | 14665 | 1.860 |
Why?
| Temperature | 11 | 2016 | 176 | 1.850 |
Why?
| Mice, Nude | 17 | 2018 | 268 | 1.820 |
Why?
| Fluorescent Dyes | 8 | 2020 | 110 | 1.820 |
Why?
| Mice | 40 | 2022 | 6442 | 1.740 |
Why?
| Phototherapy | 11 | 2019 | 47 | 1.710 |
Why?
| Microscopy, Fluorescence | 9 | 2019 | 186 | 1.640 |
Why?
| Melanoma | 5 | 2022 | 305 | 1.560 |
Why?
| Image Cytometry | 4 | 2011 | 12 | 1.540 |
Why?
| Mesentery | 7 | 2011 | 31 | 1.520 |
Why?
| Cell Line, Tumor | 26 | 2021 | 1503 | 1.510 |
Why?
| Thermography | 5 | 2009 | 13 | 1.410 |
Why?
| Spectrum Analysis, Raman | 10 | 2020 | 62 | 1.380 |
Why?
| Plasmodium yoelii | 2 | 2022 | 14 | 1.370 |
Why?
| Single-Cell Analysis | 4 | 2019 | 57 | 1.350 |
Why?
| Malaria | 2 | 2022 | 34 | 1.340 |
Why?
| Hot Temperature | 10 | 2013 | 231 | 1.320 |
Why?
| Neoplasms | 15 | 2019 | 1340 | 1.300 |
Why?
| Melanoma, Experimental | 3 | 2016 | 47 | 1.250 |
Why?
| Magnetite Nanoparticles | 4 | 2019 | 22 | 1.250 |
Why?
| Cell Separation | 5 | 2008 | 99 | 1.170 |
Why?
| Nanostructures | 6 | 2019 | 48 | 1.120 |
Why?
| Lymph | 6 | 2019 | 20 | 1.100 |
Why?
| Lymphatic Vessels | 4 | 2019 | 46 | 1.090 |
Why?
| Blood Volume | 2 | 2019 | 70 | 1.070 |
Why?
| Staphylococcus aureus | 4 | 2019 | 360 | 1.040 |
Why?
| Quantum Dots | 3 | 2017 | 14 | 1.020 |
Why?
| Photometry | 5 | 2010 | 15 | 1.000 |
Why?
| Anemia, Sickle Cell | 3 | 2016 | 98 | 1.000 |
Why?
| Green Fluorescent Proteins | 3 | 2019 | 106 | 0.970 |
Why?
| Spectrum Analysis | 8 | 2016 | 73 | 0.970 |
Why?
| Breast Neoplasms | 7 | 2018 | 1245 | 0.940 |
Why?
| Fluorescence | 5 | 2018 | 46 | 0.930 |
Why?
| Blood Vessels | 3 | 2019 | 76 | 0.930 |
Why?
| Microscopy, Confocal | 2 | 2015 | 103 | 0.910 |
Why?
| Staphylococcal Infections | 2 | 2019 | 299 | 0.890 |
Why?
| Humans | 61 | 2021 | 54277 | 0.800 |
Why?
| Plant Leaves | 2 | 2011 | 43 | 0.770 |
Why?
| Rats | 15 | 2019 | 3613 | 0.770 |
Why?
| Skin | 2 | 2020 | 441 | 0.750 |
Why?
| Drug Carriers | 3 | 2017 | 73 | 0.750 |
Why?
| Skin Neoplasms | 3 | 2011 | 519 | 0.750 |
Why?
| Ultrasonography | 4 | 2020 | 489 | 0.740 |
Why?
| Graphite | 2 | 2019 | 29 | 0.730 |
Why?
| Melanins | 5 | 2021 | 28 | 0.700 |
Why?
| Protein Engineering | 1 | 2019 | 21 | 0.690 |
Why?
| Nanomedicine | 5 | 2017 | 21 | 0.690 |
Why?
| Apoptosis | 4 | 2018 | 1294 | 0.680 |
Why?
| Diagnostic Imaging | 4 | 2017 | 183 | 0.670 |
Why?
| Nanocomposites | 1 | 2019 | 9 | 0.660 |
Why?
| Early Detection of Cancer | 4 | 2022 | 170 | 0.660 |
Why?
| Disease Models, Animal | 5 | 2021 | 1654 | 0.640 |
Why?
| Cardiovascular Diseases | 4 | 2021 | 480 | 0.640 |
Why?
| Silicon Dioxide | 2 | 2020 | 15 | 0.640 |
Why?
| Blood Circulation | 3 | 2021 | 19 | 0.620 |
Why?
| Hemorheology | 3 | 2011 | 12 | 0.600 |
Why?
| Nanospheres | 2 | 2017 | 9 | 0.590 |
Why?
| Leukocytes | 3 | 2016 | 80 | 0.590 |
Why?
| Molecular Probes | 1 | 2016 | 12 | 0.580 |
Why?
| Luminescent Proteins | 2 | 2014 | 63 | 0.580 |
Why?
| Nanotubes | 7 | 2020 | 29 | 0.570 |
Why?
| Drug Delivery Systems | 5 | 2019 | 142 | 0.560 |
Why?
| Lasers, Semiconductor | 2 | 2022 | 10 | 0.560 |
Why?
| Image Enhancement | 2 | 2006 | 55 | 0.560 |
Why?
| Hemeproteins | 1 | 2016 | 4 | 0.560 |
Why?
| Parasitemia | 1 | 2016 | 4 | 0.560 |
Why?
| Pancreatic Neoplasms | 3 | 2020 | 232 | 0.550 |
Why?
| Embolism | 1 | 2016 | 26 | 0.550 |
Why?
| Cell Survival | 8 | 2018 | 671 | 0.550 |
Why?
| Exosomes | 1 | 2016 | 43 | 0.550 |
Why?
| Antineoplastic Agents | 4 | 2017 | 1286 | 0.540 |
Why?
| Lymphatic Metastasis | 4 | 2020 | 258 | 0.540 |
Why?
| Magnetics | 3 | 2011 | 44 | 0.530 |
Why?
| Laser Scanning Cytometry | 3 | 2010 | 8 | 0.520 |
Why?
| Escherichia coli | 2 | 2007 | 259 | 0.510 |
Why?
| Image Interpretation, Computer-Assisted | 5 | 2007 | 111 | 0.500 |
Why?
| Staining and Labeling | 3 | 2013 | 104 | 0.500 |
Why?
| Blood Cells | 4 | 2012 | 50 | 0.500 |
Why?
| Pharmaceutical Preparations | 1 | 2015 | 81 | 0.490 |
Why?
| Plant Roots | 2 | 2011 | 34 | 0.480 |
Why?
| Optical Phenomena | 2 | 2017 | 11 | 0.470 |
Why?
| Laser Therapy | 3 | 2009 | 91 | 0.470 |
Why?
| Neoplastic Stem Cells | 3 | 2020 | 105 | 0.460 |
Why?
| Models, Biological | 2 | 2009 | 806 | 0.460 |
Why?
| Hyperthermia, Induced | 4 | 2019 | 121 | 0.460 |
Why?
| Infrared Rays | 3 | 2016 | 26 | 0.460 |
Why?
| Signal Processing, Computer-Assisted | 3 | 2011 | 91 | 0.460 |
Why?
| Blood Coagulation | 2 | 2011 | 61 | 0.460 |
Why?
| Neoplasm Metastasis | 2 | 2015 | 250 | 0.450 |
Why?
| Neoplasm Proteins | 2 | 2006 | 347 | 0.450 |
Why?
| Nicotine | 2 | 2005 | 209 | 0.450 |
Why?
| Mosquito Control | 1 | 2013 | 4 | 0.450 |
Why?
| Aedes | 1 | 2013 | 12 | 0.440 |
Why?
| Lymph Nodes | 3 | 2020 | 285 | 0.440 |
Why?
| Scattering, Radiation | 3 | 2009 | 32 | 0.430 |
Why?
| Early Diagnosis | 4 | 2016 | 91 | 0.420 |
Why?
| Carotenoids | 1 | 2012 | 50 | 0.410 |
Why?
| Reproducibility of Results | 6 | 2021 | 1281 | 0.410 |
Why?
| Xylem | 1 | 2011 | 3 | 0.400 |
Why?
| Phloem | 1 | 2011 | 3 | 0.400 |
Why?
| Silver | 3 | 2017 | 50 | 0.400 |
Why?
| Bacteremia | 1 | 2012 | 106 | 0.390 |
Why?
| KB Cells | 1 | 2010 | 5 | 0.380 |
Why?
| Cytochromes c | 1 | 2010 | 34 | 0.380 |
Why?
| Thromboembolism | 1 | 2011 | 56 | 0.380 |
Why?
| Gene Expression Regulation, Plant | 1 | 2010 | 51 | 0.380 |
Why?
| Rats, Sprague-Dawley | 6 | 2019 | 1765 | 0.380 |
Why?
| Microscopy, Electron, Transmission | 4 | 2017 | 83 | 0.370 |
Why?
| Optics and Photonics | 2 | 2018 | 12 | 0.370 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2013 | 434 | 0.370 |
Why?
| Models, Animal | 2 | 2010 | 265 | 0.350 |
Why?
| Microscopy, Video | 2 | 2006 | 20 | 0.350 |
Why?
| Cells | 1 | 2009 | 3 | 0.350 |
Why?
| Etoposide | 1 | 2009 | 83 | 0.350 |
Why?
| Time Factors | 7 | 2018 | 3211 | 0.350 |
Why?
| Spectrophotometry, Infrared | 1 | 2009 | 9 | 0.340 |
Why?
| Color | 3 | 2016 | 27 | 0.340 |
Why?
| Blood Chemical Analysis | 1 | 2009 | 32 | 0.340 |
Why?
| Adipocytes | 1 | 2010 | 128 | 0.330 |
Why?
| Microscopy, Acoustic | 1 | 2008 | 5 | 0.330 |
Why?
| Photochemistry | 4 | 2010 | 17 | 0.320 |
Why?
| Receptors, Cell Surface | 3 | 2019 | 135 | 0.320 |
Why?
| Cell Culture Techniques | 2 | 2005 | 109 | 0.310 |
Why?
| Lenses | 1 | 2007 | 5 | 0.310 |
Why?
| Antibodies | 4 | 2014 | 174 | 0.310 |
Why?
| Colony Count, Microbial | 1 | 2007 | 70 | 0.300 |
Why?
| Myocardial Infarction | 1 | 2011 | 406 | 0.300 |
Why?
| Escherichia coli Infections | 1 | 2007 | 35 | 0.300 |
Why?
| Spectrophotometry | 3 | 2016 | 34 | 0.290 |
Why?
| Flow Injection Analysis | 1 | 2006 | 2 | 0.290 |
Why?
| Mitochondria | 1 | 2010 | 454 | 0.280 |
Why?
| Lymphocytes | 2 | 2005 | 165 | 0.280 |
Why?
| Imaging, Three-Dimensional | 2 | 2012 | 161 | 0.280 |
Why?
| Doxorubicin | 2 | 2019 | 255 | 0.280 |
Why?
| Vinblastine | 1 | 2006 | 41 | 0.280 |
Why?
| Models, Theoretical | 2 | 2007 | 188 | 0.280 |
Why?
| Mesenteric Arteries | 1 | 2006 | 45 | 0.280 |
Why?
| Drug Evaluation, Preclinical | 1 | 2007 | 157 | 0.280 |
Why?
| Neoplasm Recurrence, Local | 4 | 2021 | 643 | 0.270 |
Why?
| Stroke | 1 | 2011 | 532 | 0.260 |
Why?
| Antibodies, Neoplasm | 1 | 2005 | 35 | 0.260 |
Why?
| Indocyanine Green | 2 | 2019 | 37 | 0.260 |
Why?
| Image Processing, Computer-Assisted | 2 | 2018 | 252 | 0.250 |
Why?
| Carcinoma | 1 | 2006 | 156 | 0.250 |
Why?
| Pancreas | 1 | 2005 | 81 | 0.250 |
Why?
| K562 Cells | 1 | 2005 | 48 | 0.250 |
Why?
| Microcirculation | 1 | 2005 | 85 | 0.250 |
Why?
| Injections, Intravenous | 2 | 2017 | 152 | 0.240 |
Why?
| Equipment Design | 4 | 2007 | 314 | 0.240 |
Why?
| Lymphatic System | 2 | 2018 | 15 | 0.230 |
Why?
| Systems Integration | 4 | 2007 | 23 | 0.220 |
Why?
| Folic Acid | 2 | 2017 | 141 | 0.220 |
Why?
| Sensitivity and Specificity | 4 | 2014 | 929 | 0.220 |
Why?
| Materials Testing | 2 | 2017 | 65 | 0.210 |
Why?
| Anti-Bacterial Agents | 2 | 2019 | 834 | 0.210 |
Why?
| Mice, Inbred C57BL | 3 | 2019 | 2021 | 0.210 |
Why?
| Carcinoma, Hepatocellular | 2 | 2021 | 200 | 0.210 |
Why?
| Plasmodium falciparum | 1 | 2022 | 15 | 0.210 |
Why?
| Cell Count | 2 | 2019 | 175 | 0.200 |
Why?
| Huntington Disease | 1 | 2021 | 26 | 0.200 |
Why?
| Adenocarcinoma | 1 | 2005 | 428 | 0.190 |
Why?
| Mice, Transgenic | 2 | 2016 | 637 | 0.190 |
Why?
| Rheology | 2 | 2011 | 12 | 0.190 |
Why?
| Ultrasonic Therapy | 1 | 2001 | 40 | 0.190 |
Why?
| Particle Size | 2 | 2013 | 87 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 4 | 2019 | 1516 | 0.180 |
Why?
| Cell Line | 5 | 2019 | 1125 | 0.180 |
Why?
| HeLa Cells | 3 | 2009 | 283 | 0.180 |
Why?
| Stromal Cells | 1 | 2020 | 77 | 0.170 |
Why?
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 13 | 0.170 |
Why?
| Sentinel Lymph Node Biopsy | 1 | 2020 | 124 | 0.170 |
Why?
| Phagocytosis | 2 | 2017 | 52 | 0.170 |
Why?
| Muscle Cells | 1 | 2019 | 24 | 0.170 |
Why?
| Pseudomonas aeruginosa | 1 | 2019 | 85 | 0.170 |
Why?
| Tomography, Optical Coherence | 1 | 2020 | 118 | 0.170 |
Why?
| Staurosporine | 1 | 2018 | 12 | 0.170 |
Why?
| Meningeal Neoplasms | 1 | 2019 | 52 | 0.170 |
Why?
| Muscle Contraction | 1 | 2019 | 115 | 0.160 |
Why?
| Diagnostic Techniques and Procedures | 1 | 2018 | 6 | 0.160 |
Why?
| Therapeutics | 1 | 2018 | 6 | 0.160 |
Why?
| Kinetics | 2 | 2011 | 696 | 0.160 |
Why?
| Computer Systems | 2 | 2009 | 22 | 0.160 |
Why?
| Female | 8 | 2021 | 28542 | 0.150 |
Why?
| Microscopy, Phase-Contrast | 2 | 2009 | 14 | 0.150 |
Why?
| Lymphatic Abnormalities | 1 | 2017 | 22 | 0.150 |
Why?
| Tumor Cells, Cultured | 2 | 2009 | 505 | 0.150 |
Why?
| Histocompatibility Antigens Class II | 1 | 2017 | 39 | 0.150 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 37 | 0.150 |
Why?
| Galectin 1 | 1 | 2017 | 21 | 0.150 |
Why?
| Bacterial Infections | 1 | 2018 | 103 | 0.150 |
Why?
| Liver Neoplasms | 1 | 2021 | 343 | 0.140 |
Why?
| Polyethylene Glycols | 1 | 2017 | 103 | 0.140 |
Why?
| Hemoglobin, Sickle | 1 | 2016 | 6 | 0.140 |
Why?
| Biocompatible Materials | 1 | 2017 | 71 | 0.140 |
Why?
| Cells, Cultured | 3 | 2007 | 1720 | 0.140 |
Why?
| Nonlinear Dynamics | 1 | 2016 | 22 | 0.140 |
Why?
| Caenorhabditis elegans | 2 | 2021 | 146 | 0.140 |
Why?
| Schizonts | 1 | 2016 | 3 | 0.140 |
Why?
| Dendritic Cells | 1 | 2017 | 137 | 0.140 |
Why?
| Photochemical Processes | 2 | 2014 | 9 | 0.140 |
Why?
| Ear | 1 | 2016 | 17 | 0.140 |
Why?
| Ampicillin | 1 | 2016 | 7 | 0.140 |
Why?
| Host-Parasite Interactions | 1 | 2016 | 17 | 0.140 |
Why?
| Transducers | 1 | 2016 | 20 | 0.140 |
Why?
| Equipment Failure Analysis | 2 | 2006 | 48 | 0.140 |
Why?
| Ultrasonics | 1 | 2016 | 33 | 0.140 |
Why?
| Computers, Handheld | 1 | 2016 | 27 | 0.140 |
Why?
| Genes, Reporter | 1 | 2016 | 98 | 0.140 |
Why?
| Surface Plasmon Resonance | 3 | 2017 | 24 | 0.130 |
Why?
| Brain Neoplasms | 1 | 2019 | 297 | 0.130 |
Why?
| Drug Compounding | 1 | 2015 | 26 | 0.130 |
Why?
| Workflow | 1 | 2015 | 56 | 0.130 |
Why?
| Biological Transport | 1 | 2015 | 184 | 0.130 |
Why?
| Mammography | 1 | 2015 | 99 | 0.130 |
Why?
| Blood Platelets | 2 | 2021 | 262 | 0.120 |
Why?
| Cell Tracking | 1 | 2014 | 2 | 0.120 |
Why?
| Necrosis | 2 | 2005 | 209 | 0.120 |
Why?
| Magnetic Phenomena | 1 | 2013 | 6 | 0.120 |
Why?
| Neoplasm Staging | 1 | 2016 | 788 | 0.120 |
Why?
| Cerebrospinal Fluid | 1 | 2013 | 34 | 0.110 |
Why?
| Algorithms | 2 | 2010 | 681 | 0.110 |
Why?
| Biopsy | 1 | 2015 | 672 | 0.110 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.110 |
Why?
| Complementary Therapies | 1 | 2012 | 25 | 0.110 |
Why?
| Lipoproteins | 1 | 2012 | 44 | 0.110 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2013 | 210 | 0.110 |
Why?
| Intracellular Space | 1 | 2012 | 27 | 0.100 |
Why?
| Radiation Dosage | 1 | 2013 | 176 | 0.100 |
Why?
| Gentian Violet | 1 | 2011 | 4 | 0.100 |
Why?
| Optical Fibers | 1 | 2011 | 9 | 0.100 |
Why?
| Erythrocyte Deformability | 1 | 2011 | 2 | 0.100 |
Why?
| Erythrocyte Aggregation | 1 | 2011 | 3 | 0.100 |
Why?
| Trypan Blue | 1 | 2011 | 9 | 0.100 |
Why?
| Blood Viscosity | 1 | 2011 | 4 | 0.100 |
Why?
| Succinimides | 1 | 2011 | 7 | 0.100 |
Why?
| Hematologic Tests | 1 | 2011 | 11 | 0.100 |
Why?
| Fluoresceins | 1 | 2011 | 12 | 0.100 |
Why?
| Methylene Blue | 1 | 2011 | 11 | 0.100 |
Why?
| Hematocrit | 1 | 2011 | 51 | 0.100 |
Why?
| Splanchnic Circulation | 1 | 2011 | 44 | 0.100 |
Why?
| Platelet Aggregation | 1 | 2011 | 77 | 0.100 |
Why?
| Carotid Arteries | 1 | 2011 | 88 | 0.100 |
Why?
| Aquaporin 2 | 1 | 2010 | 5 | 0.100 |
Why?
| Blood Loss, Surgical | 1 | 2011 | 75 | 0.100 |
Why?
| Bacteria | 1 | 2013 | 249 | 0.100 |
Why?
| Hemoglobins | 1 | 2011 | 119 | 0.100 |
Why?
| Immunoconjugates | 1 | 2011 | 40 | 0.090 |
Why?
| Biopsy, Needle | 1 | 2011 | 197 | 0.090 |
Why?
| Mastectomy, Segmental | 1 | 2011 | 97 | 0.090 |
Why?
| Microarray Analysis | 1 | 2010 | 79 | 0.090 |
Why?
| Neoplasm Transplantation | 1 | 2010 | 89 | 0.090 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2011 | 94 | 0.090 |
Why?
| Spectroscopy, Near-Infrared | 1 | 2010 | 62 | 0.090 |
Why?
| Chylomicrons | 1 | 2010 | 4 | 0.090 |
Why?
| Oscillometry | 1 | 2010 | 9 | 0.090 |
Why?
| Neovascularization, Pathologic | 1 | 2011 | 168 | 0.090 |
Why?
| Plant Oils | 1 | 2010 | 18 | 0.090 |
Why?
| Survival Rate | 1 | 2013 | 945 | 0.090 |
Why?
| Male | 5 | 2021 | 27576 | 0.090 |
Why?
| Folate Receptors, GPI-Anchored | 1 | 2009 | 7 | 0.090 |
Why?
| Water | 1 | 2010 | 93 | 0.090 |
Why?
| Ablation Techniques | 1 | 2009 | 23 | 0.090 |
Why?
| Diffusion | 1 | 2009 | 17 | 0.090 |
Why?
| Lymphography | 1 | 2009 | 9 | 0.090 |
Why?
| Catheter Ablation | 1 | 2011 | 129 | 0.090 |
Why?
| Endothelium, Lymphatic | 1 | 2009 | 12 | 0.090 |
Why?
| Extracellular Space | 1 | 2009 | 42 | 0.090 |
Why?
| Molecular Mimicry | 1 | 2009 | 69 | 0.090 |
Why?
| Phantoms, Imaging | 1 | 2010 | 123 | 0.090 |
Why?
| Drug Synergism | 1 | 2009 | 167 | 0.090 |
Why?
| Feasibility Studies | 2 | 2011 | 406 | 0.080 |
Why?
| Polymerase Chain Reaction | 1 | 2010 | 526 | 0.080 |
Why?
| Cytoplasm | 1 | 2009 | 103 | 0.080 |
Why?
| Cell Death | 1 | 2009 | 226 | 0.080 |
Why?
| Genetic Therapy | 2 | 2006 | 120 | 0.080 |
Why?
| Mice, Inbred BALB C | 2 | 2021 | 365 | 0.080 |
Why?
| Neoplasms, Experimental | 1 | 2008 | 117 | 0.080 |
Why?
| Refractometry | 1 | 2007 | 7 | 0.080 |
Why?
| Blood Coagulation Tests | 1 | 2007 | 23 | 0.080 |
Why?
| Carrier Proteins | 1 | 2009 | 359 | 0.080 |
Why?
| Magnetic Resonance Imaging | 2 | 2011 | 1635 | 0.070 |
Why?
| Molecular Conformation | 1 | 2006 | 69 | 0.070 |
Why?
| Virology | 1 | 2006 | 6 | 0.070 |
Why?
| Oxidative Stress | 1 | 2012 | 923 | 0.070 |
Why?
| Blood Flow Velocity | 1 | 2006 | 110 | 0.070 |
Why?
| Adenoviridae | 1 | 2006 | 60 | 0.070 |
Why?
| Genetic Vectors | 1 | 2006 | 138 | 0.070 |
Why?
| Microscopy, Electron | 1 | 2005 | 94 | 0.070 |
Why?
| Metals | 1 | 2005 | 38 | 0.070 |
Why?
| Metabolic Clearance Rate | 1 | 2005 | 75 | 0.060 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 868 | 0.060 |
Why?
| Rats, Inbred F344 | 1 | 2005 | 202 | 0.060 |
Why?
| Microspectrophotometry | 1 | 2005 | 1 | 0.060 |
Why?
| Protein Transport | 1 | 2005 | 189 | 0.060 |
Why?
| Cluster Analysis | 1 | 2005 | 253 | 0.060 |
Why?
| Video Recording | 1 | 2005 | 94 | 0.060 |
Why?
| Computer Simulation | 1 | 2005 | 326 | 0.060 |
Why?
| Varicose Veins | 1 | 2004 | 19 | 0.060 |
Why?
| Forearm | 1 | 2004 | 40 | 0.060 |
Why?
| Veins | 1 | 2004 | 75 | 0.060 |
Why?
| Photobiology | 1 | 2002 | 2 | 0.050 |
Why?
| Biophysics | 1 | 2002 | 18 | 0.050 |
Why?
| Biophysical Phenomena | 1 | 2002 | 21 | 0.050 |
Why?
| Liposomes | 1 | 2002 | 53 | 0.050 |
Why?
| Prognosis | 2 | 2021 | 2074 | 0.050 |
Why?
| Microwaves | 1 | 2021 | 12 | 0.050 |
Why?
| Chemoembolization, Therapeutic | 1 | 2021 | 12 | 0.050 |
Why?
| Reference Standards | 1 | 2021 | 61 | 0.050 |
Why?
| Microspheres | 1 | 2020 | 32 | 0.050 |
Why?
| Recombinant Fusion Proteins | 1 | 2021 | 208 | 0.050 |
Why?
| Pancreatic Stellate Cells | 1 | 2020 | 2 | 0.050 |
Why?
| Spheroids, Cellular | 1 | 2020 | 25 | 0.040 |
Why?
| Peptides | 1 | 2021 | 273 | 0.040 |
Why?
| Optical Imaging | 1 | 2020 | 27 | 0.040 |
Why?
| Burns | 1 | 2002 | 171 | 0.040 |
Why?
| Organ Culture Techniques | 1 | 2019 | 54 | 0.040 |
Why?
| Quartz Crystal Microbalance Techniques | 1 | 2019 | 2 | 0.040 |
Why?
| Antibiotics, Antineoplastic | 1 | 2019 | 84 | 0.040 |
Why?
| Combined Modality Therapy | 1 | 2001 | 691 | 0.040 |
Why?
| Tumor Microenvironment | 1 | 2020 | 215 | 0.040 |
Why?
| Treatment Outcome | 1 | 2009 | 5558 | 0.040 |
Why?
| Coated Materials, Biocompatible | 1 | 2017 | 38 | 0.040 |
Why?
| Wounds and Injuries | 1 | 2001 | 315 | 0.040 |
Why?
| Young Adult | 2 | 2021 | 4298 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 126 | 0.030 |
Why?
| Biofilms | 1 | 2018 | 200 | 0.030 |
Why?
| Cell Differentiation | 1 | 2017 | 717 | 0.030 |
Why?
| MCF-7 Cells | 1 | 2014 | 78 | 0.030 |
Why?
| Mammary Neoplasms, Animal | 1 | 2013 | 37 | 0.030 |
Why?
| Cell Proliferation | 1 | 2017 | 1069 | 0.030 |
Why?
| Macrophages | 1 | 2016 | 400 | 0.030 |
Why?
| Aged | 2 | 2021 | 9984 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 548 | 0.030 |
Why?
| Vacuum | 1 | 2011 | 14 | 0.030 |
Why?
| Middle Aged | 2 | 2021 | 12962 | 0.020 |
Why?
| Adult | 2 | 2021 | 14279 | 0.020 |
Why?
| Ultrasonography, Interventional | 1 | 2011 | 145 | 0.020 |
Why?
| Pilot Projects | 1 | 2011 | 779 | 0.020 |
Why?
| Gene Targeting | 1 | 2006 | 33 | 0.020 |
Why?
| Binding Sites | 1 | 2006 | 425 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2011 | 3398 | 0.010 |
Why?
| Risk Factors | 1 | 2011 | 3906 | 0.010 |
Why?
| Adolescent | 1 | 2011 | 6921 | 0.010 |
Why?
|
|
Zharov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|